Filing Details

Accession Number:
0001415889-19-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-02 17:58:32
Reporting Period:
2018-12-28
Accepted Time:
2019-01-02 17:58:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604191 Azurrx Biopharma Inc. AZRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1117167 J Charles Casamento
Suite 304
Brooklyn NY 11226
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-28 9,000 $1.41 56,500 No 4 P Direct
Common Stock Acquisiton 2018-12-28 7,500 $1.29 64,000 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Footnotes
  1. Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.